06:11 AM EDT, 09/01/2026 (MT Newswires) -- Reckitt Benckiser Group (RKT.L) subsidiary Mead Johnson won a jury verdict in the Inman case in the US District Court for the Northern District of Illinois, the first bellwether trial against the company in federal multidistrict litigation over allegations concerning necrotizing enterocolitis, or NEC. The case involved claims that the nutrition company's Enfamil preterm infant formula causes NEC, a serious gastrointestinal condition that primarily affects premature infants, according to a Monday release. Mead Johnson said it now has no outstanding jury verdicts in the overall NEC litigation.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.